for Research on Cancer in Lyon, France, and the WHO Centre for Health Development in Kobe, Japan. Additional offices include those in Pristina; the West Bank and Gaza; the US-Mexico Border Field Office in El Paso; the Office of the Caribbean Program Coordination in Barbados; and the Northern Micronesia office. There will generally be one WHO country office in the capital, occasionally accompanied by satellite-offices in the provinces or sub-regions of the country in question. The country office is headed by a WHO Representative (WR). , the only WHO Representative outside Europe to be a national of that country was for the Libyan Arab Jamahiriya ("Libya"); all other staff was international. WHO Representatives in the Region termed the Americas are referred to as PAHO/WHO Representatives. In Europe, WHO Representatives also serve as head of the country office, and are nationals except for Serbia; there are also heads of the country office in Albania, the Russian Federation, Tajikistan, Turkey, and Uzbekistan. The WR is a member of the UN system country team which is coordinated by the UN System Resident Coordinator. The country office consists of the WR, and several health and other experts, both foreign and local, as well as the necessary support staff. The main functions of WHO country offices include being the primary adviser of that country's government in matters of health and pharmaceutical policies. Financing and partnerships Present The WHO is financed by contributions from member states and outside donors. As of 2020, the biggest contributor is the United States, which gives over $400 million annually. U.S. contributions to the WHO are funded through the U.S. State Department's account for Contributions to International Organizations (CIO). In 2018 the largest contributors ($150+ each) were the United States, Bill & Melinda Gates Foundation, United Kingdom, Germany and GAVI, the Vaccine Alliance. The WHO Executive Board formed a Working Group on Sustainable Financing in 2021, charged to rethink WHO's funding strategy and present recommendations. Its recommendations were adopted by the 2022 World Health Assembly. In April 2020, U.S. President Donald Trump, supported by a group of members of his party, announced that his administration would halt funding to the WHO. Funds previously earmarked for the WHO were to be held for 60–90 days pending an investigation into the WHO's handling of the COVID-19 pandemic, particularly in respect to the organization's purported relationship with China. The announcement was immediately criticized by